Stefanie Wiebe
Muenster, NW 48145, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
Journal: Cancers
Published: May 18, 2020
Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia.
Journal: JAAD case reports
Published: April 25, 2018
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
Journal: PloS one
Published: July 13, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Journal: Cancer research and treatment
Published: March 15, 2016
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.
Journal: Annals of hematology
Published: February 02, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
Journal: Cancer immunology research
Published: September 23, 2014
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia.
Journal: Annals of hematology
Published: July 22, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026